Remember that this news release ( the first of 3 on the "clouded subject" ), led to a 29 CENT financing to insiders, stock they still HOLD.

Is it the Americans turn to "do us" before we make things easy to understand?

VERY disappointed at the behaviour of the group pulling the strings here.

Patient Home, Concordia, Telesta, Theralase, Acerus....step up Spectral yur up to bat again!

SPECTRAL ANNOUNCES STATUS OF SECOND INTERIM ANALYSIS TORONTO, Canada – January 28, 2014 – Spectral Diagnostics Inc. (TSX:SDI) (OTCQX:DIAGF) (“Spectral” or the “Company”), a Phase III company developing the first theranostic treatment for patients with severe sepsis and septic shock, today announced that the Data Safety Monitoring Board (DSMB) has evaluated the safety, efficacy and futility of its EUPHRATES trial based on actual data for 184 randomized patients followed for 28 days. The DSMB has recommended that the trial continue, but has asked that further analysis be performed before recalculation of the trial’s sample size is finalized. “The Company will await the specifics of the DSMB report, expected soon, before determining next steps in its clinical and commercial pathway,” said Dr. Paul Walker, President and CEO of Spectral Diagnostics